Aurora Financial Journal

IM Cannabis Corp. (IMCC)

NASDAQ · Health care · Medicinal Chemicals & Botanical Products · Financial statements, TTM figures and earnings dates

In fiscal year 2025 (ended December 31, 2025), IM Cannabis Corp. reported revenue of C$54.7M and net income of −C$11.3M. Annual financial statements are available for fiscal years 2019 to 2025, taken from the company's filings with the SEC.

Open interactive financials →

Key financials

CADFY2025
2025-12-31
FY2024
2024-12-31
FY2023
2023-12-31
FY2022
2022-12-31
FY2021
2021-12-31
Income statement
RevenueC$54.7MC$54.0MC$48.8MC$54.3MC$34.1M
Gross profitC$9.7MC$8.5MC$9.8MC$9.2MC$6.3M
Operating income−C$11.6M−C$10.2M−C$12.8M−C$30.8M−C$23.0M
Net income−C$11.3M−C$10.6M−C$9.5M−C$188.9M−C$17.8M
Diluted EPS–−C$4.51−C$4.45−C$161.88−C$6.70
Cash flow
Operating cash flowC$4.7M−C$1.1M−C$8.1M−C$12.6M−C$34.4M
Capital expenditureC$13.0KC$156.0KC$581.0KC$1.6MC$4.6M
Free cash flowC$4.7M−C$1.2M−C$8.7M−C$14.2M−C$39.0M
Balance sheet
Cash and equivalentsC$2.7MC$863.0KC$1.8MC$2.4MC$13.9M
Total assetsC$31.7MC$39.2MC$48.8MC$60.7MC$287.4M
Total liabilitiesC$35.4MC$36.0MC$35.1MC$36.9MC$82.4M
Total debtC$15.3MC$15.6MC$12.5MC$9.6MC$9.9M
Shareholders' equity−C$3.7MC$5.2MC$14.5MC$22.7MC$201.2M

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in CAD as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full IMCC page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, the statements exactly as filed with the SEC, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open IMCC financials →